Krsnaa Diagnostics , one of India's leading diagnostic service providers, has announced strong financial results for the first quarter, demonstrating significant growth across key metrics.

Financial Highlights

The company reported a consolidated revenue of 1,930.00 million rupees for Q1, marking a 13% increase from 1,702.00 million rupees in the same period last year. This growth was primarily driven by the operationalization of new centers, improved footfall across existing facilities, and enhanced operational efficiency.

Krsnaa Diagnostics' EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) saw a substantial rise of 19% year-over-year, reaching 524.00 million rupees compared to 442.00 million rupees in the corresponding quarter of the previous year. The EBITDA margin improved to 27% from 26%, reflecting the company's focus on operational excellence.

Net profit for the quarter stood at 205.00 million rupees, up 15% from 179.00 million rupees in the same quarter of the previous year. The company maintained a steady profit margin of 11%, showcasing its ability to grow profitably in a competitive market.

Operational Performance

During the quarter, Krsnaa Diagnostics served approximately 5 million patients and performed around 16 million tests, highlighting the company's extensive reach and capacity. The company continued to expand its presence, with 145 CT centers and 40 MRI centers operational by the end of the quarter.

Strategic Developments

Krsnaa Diagnostics has made significant strides in its retail expansion strategy. The company reported a substantial increase in retail touchpoints, growing from 362 to 2,414 year-over-year. This expansion has led to a remarkable surge in retail revenue, which rose from 15.00 million rupees to 118.00 million rupees year-over-year.

The retail segment's contribution to the group's revenue has also seen a notable shift, increasing from 1% to 6%. This growth underscores the company's successful efforts in diversifying its revenue streams and penetrating the direct-to-consumer market.

Future Outlook

Krsnaa Diagnostics is poised for further growth, with plans to expand its network to over 200 CT/MRI centers upon completion of its existing order book. This expansion is expected to cement the company's position as one of Asia's largest radiology players.

Additionally, the company has secured a significant project in Rajasthan under the National Health Mission, which will further extend its reach in pathology services. This project involves establishing 42 state-of-the-art Mother Labs, 135 Satellite Labs, and over 1,300 Collection Centers across the state.

Management Commentary

Yash Mutha, Managing Director of Krsnaa Diagnostics, expressed optimism about the company's performance and future prospects. He stated, "Our Q1 results reflect our commitment to delivering high-quality, affordable diagnostic services across India. The significant growth in our retail segment and the landmark Rajasthan project underscore our strategy to expand our reach and impact in both public and private healthcare sectors."

As Krsnaa Diagnostics continues to expand its footprint and enhance its service offerings, it remains well-positioned to capitalize on the growing demand for quality diagnostic services in India.

About Krsnaa Diagnostics

Krsnaa Diagnostics Limited is one of India's fastest-growing diagnostic service providers, offering a comprehensive range of radiology, pathology, and tele-radiology services. With a presence in 18 states and union territories, the company has served over 70 million patients since its inception, focusing on providing quality and inclusive diagnostic services at affordable rates across various segments, with a particular emphasis on the Public Private Partnership model.

Krsnaa Diagnostics Limited has announced a significant partnership that could potentially expand its presence in the healthcare sector of Rajasthan. The company, in consortium with Telecommunications Consultants India Ltd. (TCIL), has executed an agreement with the National Health Mission, Rajasthan, to provide laboratory services under the Free Diagnostics Initiative across the state.

Partnership Details

The agreement, which is part of a tender awarded by the National Health Mission, Jaipur, Rajasthan, involves implementing a HUB and SPOKE model for diagnostic services. This model is designed to improve access to quality diagnostic services in various parts of the state, potentially benefiting a large population.

Scope of Services

According to the disclosure made by Krsnaa Diagnostics to the stock exchanges, the company will be responsible for:

• Providing laboratory services under the free Diagnostic initiative
• Implementing the HUB and SPOKE model across Rajasthan
• Executing the project as per the terms outlined in the tender

Financial Impact

While the exact financial details of the contract have not been disclosed, the company stated that the size of the contract cannot be estimated at this time, as it is a new project. The impact on Krsnaa Diagnostics' financials may become clearer as the project progresses.

Strategic Importance

This partnership marks a significant step for Krsnaa Diagnostics in expanding its footprint in the public health sector. By collaborating with TCIL and the National Health Mission, the company is positioning itself to play a crucial role in enhancing healthcare accessibility in Rajasthan.

Conclusion

The agreement with the National Health Mission in Rajasthan represents a potentially significant opportunity for Krsnaa Diagnostics to expand its services and contribute to improving healthcare access in the state. As more details emerge about the implementation and financial implications of this project, stakeholders will be better positioned to assess its long-term impact on the company's growth and profitability.